Abstract
POEMS syndrome is a rare paraneoplastic condition related to myeloma. Because it is rare, there is very little known about treatment options. The use of potentially neurotoxic chemotherapeutic drugs is of concern in a disease whose major manifestation is neuropathy. Herein, we describe an extraordinary response to the combination of cyclophosphamide, bortezomib, and dexamethasone (CyBorD) in a patient with relapsed, life-threatening POEMS syndrome.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 549-550 |
| Number of pages | 2 |
| Journal | European Journal of Haematology |
| Volume | 88 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2012 |
Keywords
- POEMS
- Treatment
ASJC Scopus subject areas
- Hematology